EndoEase™ addresses a core challenge in chronic disease care: sustaining long-term treatment without compromising patient adherence. In many conditions—such as growth hormone deficiency, obesity, and endocrine disorders—patients often rely on lifelong injectable therapies. Over time, the burden of injections can lead to poor compliance, which increases healthcare costs and reduces treatment effectiveness.
Developing oral forms for large-molecule drugs like proteins and peptides has proven difficult. These molecules are often degraded by the digestive system and are too large to be absorbed across mucosal tissues like the sublingual membrane. As a result, injections have remained the default option. EndoEase™ overcomes these barriers by enabling the stable sublingual delivery of biologics. It helps translate powerful therapies into more practical, patient-friendly formats—making long-term treatment more sustainable.
Growth hormone deficiency (GHD) affects approximately 1 in 4,000 to 10,000 children worldwide. Left untreated, it can impair height development, bone strength, metabolism, and overall quality of life. Early intervention is key—yet the standard treatment involves daily growth hormone injections over a period of years, often starting in early childhood and continuing through adolescence.
For many families, this long-term injection routine becomes a source of anxiety, resistance, and treatment dropout. EndoEase™ offers a more manageable alternative that helps children and caregivers stay on track during these critical treatment years.
People living with type 1 diabetes require lifelong insulin therapy, often involving multiple injections each day. For those managing obesity or type 2 diabetes, GLP-1 receptor agonists like semaglutide also require regular self-injection. The physical and mental toll of such frequent injections often leads to missed doses and poor glycemic control.
EndoEase™ provides a simpler and more sustainable treatment experience, helping patients maintain consistency in managing complex metabolic conditions.
During IVF and other assisted reproductive treatments, women may undergo dozens or even hundreds of hormone injections in a single cycle. These regimens can cause emotional strain and side effects such as mood swings, fatigue, anxiety, insomnia, and nausea. When treatment fails, the emotional toll is often compounded by physical exhaustion.
EndoEase™ offers a gentler alternative that may ease the physical intensity and emotional stress of hormone therapy, especially during the demanding journey of fertility treatment.
